agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
4.320
-0.170 (-3.79%)
Mar 31, 2025, 9:43 AM EDT - Market open
agilon health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for agilon health stock have an average target of 3.85, with a low estimate of 2.00 and a high estimate of 9.00. The average target predicts a decrease of -10.88% from the current stock price of 4.32.
Analyst Consensus: Hold
* Price targets were last updated on Feb 26, 2025.
Analyst Ratings
The average analyst rating for agilon health stock from 18 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 2 | 2 | 2 | 1 | 1 |
| Hold | 9 | 11 | 12 | 13 | 14 | 14 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 16 | 17 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 21, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $3 → $3.5 | Buy | Maintains | $3 → $3.5 | -18.98% | Feb 26, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 26, 2025 |
| Stifel | Stifel | Hold Maintains $2 → $3 | Hold | Maintains | $2 → $3 | -30.56% | Feb 26, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 26, 2025 |
Financial Forecast
Revenue This Year
6.19B
from 6.06B
Increased by 2.12%
Revenue Next Year
7.06B
from 6.19B
Increased by 13.99%
EPS This Year
-0.36
from -0.63
EPS Next Year
-0.22
from -0.36
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.0B | 10.0B | 10.8B | ||
| Avg | 6.2B | 7.1B | 8.3B | ||
| Low | 5.7B | 5.9B | 6.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 31.6% | 61.9% | 52.6% | ||
| Avg | 2.1% | 14.0% | 17.3% | ||
| Low | -5.4% | -4.3% | -5.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.11 | -0.06 | 0.06 | |
| Avg | -0.36 | -0.22 | -0.10 | |
| Low | -0.46 | -0.31 | -0.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.